Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Natera, Inc.

Clinical trials sponsored by Natera, Inc., explained in plain language.

Natera, Inc. NTRA NASDAQ

A genetic testing company specializing in prenatal and oncology diagnostics.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 6 Not yet recruiting 4 Not yet finished but already full! 1

Blood test could replace painful heart biopsies for transplant patients

Disease control Ongoing

This study compares a simple blood test (Prospera) to the standard heart biopsy for monitoring rejection in heart transplant patients. About 250 adults waiting for or who have received a heart transplant will be randomly assigned to one of two monitoring methods. The goal is to s…

Phase: NA • Sponsor: Natera, Inc. • Aim: Disease control

Last updated Jun 27, 2026 09:08 UTC